The Reaction Project

HONcode

This site complies with the HONcode standard for trust worthy health information:
verify here.

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.

The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!

Sign In

Forgotten your password?
Request a new one here.

Facts

The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

Impressum

Privacy

Previous Newsletters

Read previous issues of our newsletter here:

April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Most Read...

Articles

In-hospital saf...	185172
Reaction in the...	111411
Project overview	104809
Medical background	104031
Project methodo...	78567

News

Research award ...	56049
IST-Africa Call...	52014
REACTION at one...	50035
REACTION videos...	48509
REACTION online...	47151

Popular Downloads

REACTION brochure	30121
Design of a mobil...	13007
D9-4 Healthcare e...	11056
D9-2 Regulatory f...	8388
2_Regulatory Fram...	6508

eHealth at Facebook

Join the discussion on EC eHealth at Facebook!

Oh no! Where's the JavaScript?
Your Web browser does not have JavaScript enabled or does not support JavaScript. Please enable JavaScript on your Web browser to properly view this Web site, or upgrade to a Web browser that does support JavaScript.

Downloads: D8.1 Clinical protocol for MDI compliance

Downloads Home > Deliverables > D8.1 Clinical protocol for MDI compliance

D8.1 Clinical protocol for MDI compliance 3

The objectives of this deliverable are to:

1. Establish a compliance monitoring application for MDI (Multiple Daily Injection) insulin pens therapy and assess its impact on the patient’s clinical pathway.
2. To establish a compliance monitoring program using a medication dispenser in order to determine its impact on the patient’s clinical pathway.

Or in the event that the insulin pen is not available due to Novo Nordisk not joining the project then:

3. Establish compliance monitoring using manual recording of time and dose of the insulin injection and the patient will be instructed to use the smart phone (or similar user terminal) to send the data to the REACTION platform and assess its impact on the patient’s clinical pathway.